Vergoeding 2020-2024 voor ATC-subgroep L04AE : Sfingosine-1-fosfaat (s1p) receptormodulatoren
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| L04AE01 Fingolimod (Gilenya ®) | 25.314.800 | 25.289.700 | 23.901.300 | 18.046.100 | 12.566.300 |
| L04AE02 Ozanimod (Zeposia ®) | 1.441 | 1.240.900 | 4.921.500 | 6.270.700 | 7.243.900 |
| L04AE03 Siponimod (Mayzent ®) | . | 1.364.100 | 3.412.200 | 3.915.400 | 3.542.300 |
| L04AE04 Ponesimod (Ponvory ®) | . | 157 | 494.430 | 3.118.100 | 4.994.700 |
| Totaal | 25.316.241 | 27.894.857 | 32.729.430 | 31.350.300 | 28.347.200 |